Resurrection Vapor LLC was warned that its e-liquid products sold through its website were deemed tobacco products subject to FDA regulation under the Family Smoking Prevention and Tobacco Control Act, but lacked required premarket authorization orders for legal marketing in the United States. The company failed to comply with FDA requirements applicable to newly deemed tobacco products (ENDS), which have been subject to FDA jurisdiction since August 8, 2016. No specific product violations such as adulteration or misbranding details were elaborated in the available letter excerpt, though the warning was issued under those statutory bases. The FDA determined the company was manufacturing and distributing these products without the necessary marketing authorization required for new or modified tobacco products.